Dell Inc. neared an agreement on Monday to sell itself to a group led by its founder and the investment firm Silver Lake for more than $23 billion, people briefed on the matter said, in what would be the biggest buyout since the financial crisis.If completed, a takeover would be the most ambitious attempt yet by Michael S. Dell to revive the company that bears his name. Such is the size of the potential...
India Ink: Five Questions For: Journalist and Author Mary Harper
Label: WorldMary Harper, the Africa editor at the BBC World Service, is the author of “Getting Somalia Wrong? Faith, War and Hope in a Shattered State,” which was released in February 2012. While she is particularly interested in Somalia, which she visits regularly, Ms. Harper has reported from several other African conflict zones, including Algeria, the Democratic Republic of Congo, Liberia, Sierra Leone and...
Bits Blog: I.B.M. Slims Down Its Big Data Offerings
Label: Technology I.B.M. is cutting the price on its least-expensive Power server computers by 50 percent, to under $6,000. The pricing move is one of a series of hardware and software announcements on Tuesday intended as a strategic push more broadly into the fast-growing market for Big Data technology and to tailor offerings for smaller businesses.The overall market for Big Data technology — hardware, software and...
Well: Expressing the Inexpressible
Label: LifestyleWhen Kyle Potvin learned she had breast cancer at the age of 41, she tracked the details of her illness and treatment in a journal. But when it came to grappling with issues of mortality, fear and hope, she found that her best outlet was poetry.How I feared chemo, afraidIt would change me.It did.Something dissolved inside me.Tears began a slow drip;I cried at the news storyOf a lost boy found in the...
Well: Expressing the Inexpressible
Label: HealthWhen Kyle Potvin learned she had breast cancer at the age of 41, she tracked the details of her illness and treatment in a journal. But when it came to grappling with issues of mortality, fear and hope, she found that her best outlet was poetry.How I feared chemo, afraidIt would change me.It did.Something dissolved inside me.Tears began a slow drip;I cried at the news storyOf a lost boy found in the...
Feb
03
Medicines Co. Licenses Rights to Cholesterol Drug
Label: Business The drug, known as ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor. The Medicines Company will pay $25 million initially and as much as $180 million later if certain development and sales goals are met, under the deal expected to...
India Ink: 'Lalla Roukh' at the Rose Theater
Label: WorldRichard Termine for The New York TimesLalla Roukh Marianne Fiset and Emiliano Gonzalez Toro starred in this work presented by Opera Lafayette on Thursday at the Rose Theater. On Thursday evening Opera Lafayette presented a graceful and witty production of Félicien David’s “Lalla Roukh” at the Rose Theater. This opéra-comique set in Mughal India had fallen into oblivion since its wildly successful...
Broad Powers Seen for Obama in Cyberstrikes
Label: TechnologyWASHINGTON — A secret legal review on the use of America’s growing arsenal of cyberweapons has concluded that President Obama has the broad power to order a pre-emptive strike if the United States detects credible evidence of a major digital attack looming from abroad, according to officials involved in the review. That decision is among several reached in recent months as the administration...
Medicines Co. Licenses Rights to Cholesterol Drug
Label: Lifestyle The drug, known as ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor. The Medicines Company will pay $25 million initially and as much as $180 million later if certain development and sales goals are met, under the deal expected to...
Medicines Co. Licenses Rights to Cholesterol Drug
Label: Health The drug, known as ALN-PCS, inhibits a protein in the body known as PCSK9. Such drugs might one day be used to treat millions of people who do not achieve sufficient cholesterol-lowering from commonly used statins, such as Lipitor. The Medicines Company will pay $25 million initially and as much as $180 million later if certain development and sales goals are met, under the deal expected to...
Subscribe to:
Posts (Atom)
Copyright © prime News. All rights reserved.
Design 
And Business Directories
